Multitargeting effects of calebin A on malignancy of CRC cells in multicellular tumor microenvironment by Buhrmann, Constanze et al.
Frontiers in Oncology | www.frontiersin.org
Edited by:
Raluca Ioana Stefan-van Staden,
National Institute of Research and





The University of Texas Rio Grande
Valley, United States
Kaiyuan Ni,
Koch Institute for Integrative Cancer






This article was submitted to
Gastrointestinal Cancers,
a section of the journal
Frontiers in Oncology
Received: 07 January 2021
Accepted: 09 September 2021
Published: 29 September 2021
Citation:
Buhrmann C, Kunnumakkara AB,
Kumar A, Samec M, Kubatka P,
Aggarwal BB and Shakibaei M (2021)
Multitargeting Effects of Calebin A on





published: 29 September 2021
doi: 10.3389/fonc.2021.650603Multitargeting Effects of Calebin
A on Malignancy of CRC Cells in
Multicellular TumorMicroenvironment
Constanze Buhrmann1,2, Ajaikumar B. Kunnumakkara3, Aviral Kumar3, Marek Samec4,
Peter Kubatka5, Bharat B. Aggarwal6 and Mehdi Shakibaei1*
1 Musculoskeletal Research Group and Tumor Biology, Chair of Vegetative Anatomy, Institute of Anatomy, Faculty of
Medicine, Ludwig-Maximilian-University Munich, Munich, Germany, 2 Institute of Anatomy and Cell Biology, Faculty of
Medicine, University of Augsburg, Augsburg, Germany, 3 Cancer Biology Laboratory & Department of Biotechnology-National
institute of Advanced Industrial Science and Technology (DBT-AIST) International Center for Translational and Environmental
Research (DAICENTER), Department of Biosciences & Bioengineering, Indian Institute of Technology Guwahati, Assam, India,
4 Department of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin,
Slovakia, 5 Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia,
6 Inflammation Research Center, San Diego, CA, United States
Background: Tumor microenvironment (TME) provides the essential prerequisite niche
for promoting cancer progression and metastasis. Calebin A, a component of Curcuma
longa, has long been investigated as a safe multitargeted agent with antitumor and anti-
inflammatory properties. However, the multicellular-TME-induced malignancy and the
antitumorigenic potential of Calebin A on colorectal cancer (CRC) cells in 3D-alginate
cultures are not yet understood, and more in-depth research is needed.
Methods: 3D-alginate tumor cultures (HCT116 cells) in the multicellular proinflammatory
TME (fibroblast cells/T lymphocytes), tumor necrosis factor beta (TNF-b)-TME (fibroblast
cells/TNF-b) were treated with/without Calebin A to address the pleiotropic actions of
Calebin A in the CRC.
Results: We found that Calebin A downmodulated proliferation, vitality, and migration of
HCT116 cells in 3D-alginate cultures in multicellular proinflammatory TME or TNF-b-TME.
In addition, Calebin A suppressed TNF-b-, similar to multicellular-TME-induced
phosphorylation of nuclear factor kappa B (NF-kB) in a concentration-dependent
manner. NF-kB-promoting proinflammatory mediators, associated with tumor growth
and antiapoptotic molecules (i.e.,MMP-9, CXCR4, Ki-67, b1-integrin, and Caspase-3) and
its translocation to the nucleus in HCT116 cells, were increased in both TME cultures. The
multicellular-TME cultures further induced the survival of cancer stem cells (CSCs)
(upregulation of CD133, CD44, and ALDH1). Last but not the least, Calebin A
suppressed multicellular-, similar to TNF-b-TME-induced rigorous upregulation of
NF-kB phosphorylation, various NF-kB-regulated gene products, CSCs activation, and
survival in 3D-alginate tumor cultures.
Conclusions: The downmodulation of multicellular proinflammatory-, similar to
TNF-b-TME-induced CRC proliferation, survival, and migration by the multitargetingSeptember 2021 | Volume 11 | Article 6506031
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CRC tumorigenesis.Keywords: Calebin A, colorectal cancer, T-lymphocyte, TNF-b, stromal cell, tumor microenvironment, NF-kBINTRODUCTION
The increasing incidence of colorectal cancer (CRC) worldwide
combined with high mortality rates necessitate the eminent need to
develop newer therapeutic strategies to regress the current negative
trend in global CRC statistics (1). CRC is a multifactorial
heterogeneous disease, as environmental factors influencing
lifestyle (diet, smoking, and alcohol) and a genetic predisposition
interact and contribute to its development. In CRC, the multistage
process from a benign polyp to an invasive adenocarcinoma is
supported with a long-lasting chronic low-grade inflammation that
promotes thedevelopmentofmalignant cells (2, 3). In fact, it hasbeen
reported that patients with chronic inflammatory diseases of the
colon, suchas chronic inflammatorybowel disease, have an increased
risk of CRC (4). It is now widely accepted that cancer’s malignant
progression ismediated by the crosstalk between tumor cells and the
surrounding stromal cells (5–7). Under the influence of cytokines,
growth factors, and chemotactic stimuli, the cancer cells recruit the
stromal fibroblasts and transform them, leading to a rearrangement
of the stromal extracellular matrix (ECM) and creating a localized
stimulating tumor microenvironment (TME) (5, 8).
The TME is multicellular and consists of a highly complex
interaction between the tumor cells, stromal cells, immune cells, and
microorganisms (9). This multicellular interaction, based on soluble
factors, transformed ECM, epigenetic modifications, immune cells,
and transformed fibroblasts, not only induces the malignancy and
metastasis of tumors but also delays and blocks the response to
tumor treatment leading to the acquisition of drug resistance (9).
Tumor-recruited fibroblasts, also known as cancer-associated
fibroblasts (CAFs), have increased migration capacity, secrete
tumor-stimulating factors into the TME, and are considered key
modulators in the process of ECM transformation in the TME (10).
Besides, tumor-associated fibroblasts, immune cells, which have a
broad spectrum of proinflammatory and anti-inflammatory
functions, play an essential role in maintaining tissue homeostasis
in the intestine, and their dysregulation leads to chronic
inflammation, which drives cancer development (11). Immune
cells such as macrophages and lymphocytes have a context-
dependent, dual function in cancer progression by orchestrating
an anti-neoplastic activity or a tumor-promoting tissue repair
response by producing reactive oxygen species and inflammatory
cytokines (12, 13). Interestingly, it has been observed that tumor-
infiltrating lymphocytes exercise protumorigenic activities and help
to evade an immunological response (14, 15). Therefore, the tumor-
associated immune cells not only inhibit the antitumor activity but
also act as prominent mediators of tumor development and
metastasis (16) and could be identified as novel therapeutic
targets circumventing CRC.
The transcription factor NF-kB regulates the activation of
several proinflammatory and antiapoptotic genes and has been2
described to be constitutively expressed inmetastatic CRC (17–19).
Moreover, the constitutive activation of the proinflammatory NF-
kB and its downstream signaling cascade in TME promotes tumor
cell survival and stimulates the misdirected immunosuppressive
activity of immune cells (14, 20).NF-kB induces theproductionand
activation of proinflammatory cytokines that are prominent
members of the tumor necrosis factor (TNF) family, such as
TNF-a and TNF-b, also known as lymphotoxin-a (21, 22). A
plethora of literature has implicated the functional role of TNF-a
and TNF-b in promoting cancer development through autocrine
and paracrine signal transduction involved in cancer cell
proliferation, invasion, and metastasis even in CRC (22–25).
Interestingly, it has been reported that lymphocytes including B-
and T-cells in the TME stimulate tumor progression by secreting
TNF-b (26). In addition, NF-kB-dependent transcription factors
were upregulated in tumor-associated lymphocytes, which
promoted proliferation/invasion and induced inflammation and
T-cell depletionpathways (27).Due to the aforementioned facts, the
focus on cytokine receptor pathways could be a promising
antitumor strategy (16). Under physiological conditions, integrins
are essential regulators of cell survival, proliferation, adhesion, and
migration in all tissues by mediating cell–cell and cell–matrix
interactions (28). Interestingly, integrins have been shown to play
a critical role in mediating the interaction between tumor cells and
TME, anddrugs targeting this interactionmayoffernewtherapeutic
potential (29, 30). Colorectal cancer stem cells (CSCs) play a central
role in the crosstalk between the tumor and its TME. They secrete
chemokines and cytokines,which in turn trigger cancermalignancy
and metastasis and could be an important target for devising new
therapeutic strategies for combating CRC (31, 32).
Mono-target therapies have proven to be unsatisfactory with
limited clinical outcomes because they cannot meet the challenge
posed by multicellular TME. Therefore, the identification of novel
multitargeting agents is imperative for effective strategies targeting
not only tumor cells but, more importantly, the multicellular TME.
Natural polyphenols have been studied extensively for their
multitargeted, antineoplastic activities in the last decade (33, 34).
Calebin A is a recently isolated pharmacologically active
component of the turmeric rhizome (Curcuma longa L.
Zingiberaceae), which is widely used in traditional Ayurvedic and
Chinese herbal medicine (35–37). Calebin A possesses antitumor
properties and has been shown to target the NF-kB signaling
pathway (35, 38). Recent research has shown that Calebin A
blocks TNF-b-induced activation of the NF-kB signaling
pathway, thereby inhibiting proliferation, invasion, and apoptosis
inCRCcells (23, 39). Furthermore,CalebinAhas great potential for
chemosensitizing CRC cells compared to the standard treatment
with 5-fluorouracil (5-FU) (39).
Given the important role that leukocyte cells, cytokines, and
stromal fibroblast cells in the TME play in promoting CRCSeptember 2021 | Volume 11 | Article 650603
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developed a novel 3D multicellular proinflammatory TME that
combines CRC cells, T-lymphocytes, and fibroblasts in vitro to
better mimic a heterogeneous proinflammatory TME similar to
in vivo conditions. We hypothesized that the functional and
biochemical interaction between tumor cells and stroma in this
TME could induce tumor metastasis by activating the NF-kB
signaling pathway, its downstream effector molecules, and CSCs.
Based on our hypothesis, this interaction could be reversed by
the natural polyphenol Calebin A treatment. In addition, using
our progressive experimental approach and the consequent
gaining of original results may help to potentially uncover
newer insights and opportunities for the treatment and clinical
management of CRC malignancy and extend our knowledge
about mechanisms associated with CRC progression.
MATERIALS AND METHODS
Antibodies and Chemicals
Monoclonal antibodies to p65, and phospho-specific p65-NF-
kB, MMP-9, CXCR4, cleaved-Caspase-3, and b1-Integrin, were
obtained from R&D Systems (Heidelberg, Germany). Antibodies
to b-actin were from Sigma-Aldrich (Taufkirchen, Germany).
Secondary rhodamine-coupled antibodies for immunofluorescence
and anti-Ki67 were from Dianova (Hamburg, Germany), and
alkaline phosphatase-linked antibodies for Western blotting were
from EMD Millipore (Schwalbach, Germany). Monoclonal anti-
ALDH1 was obtained from Acris Antibodies GmbH (Herold,
Germany). Monoclonal anti-CD133 and anti-CD44 were
purchased from Abcam PLC (Cambridge, UK). MTT reagent (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), 4′,6-
diamidino-2-phenylindole (DAPI), and alginate were from Sigma-
Aldrich (Taufkirchen, Germany). TNF-b was purchased from
eBiosciences (Frankfurt, Germany). Furthermore, TNF-b was
given as a kind gift by Genetech (South San Francisco, CA, USA).
Calebin A was a generous gift from Sabinsa Corporation (East
Windsor, NJ, USA). Calebin A was diluted as 10,000 µM stock
solution in dimethyl sulfoxide (DMSO) and further diluted in cell
culture medium for experimental investigations. The finalFrontiers in Oncology | www.frontiersin.org 3concentration of DMSO did not exceed 0.1% during
the experiments.
Cells and Cell Culture Conditions
The CRC cell line HCT116 and normal human fibroblast cells
(MRC-5) were obtained from the European Collection of Cell
Cultures (Salisbury, UK).
HCT116 and MRC-5 cells were cultured as monolayers under
standard conditions (37°C, 5% CO2) with whole-cell culture
growth medium [10% fetal calf serum (FCS)] as previously
described (40) and passaged when cells reached 70–80%
confluency. A human T-lymphocyte cell line (Jurkat cells) was
cultured in suspension with a whole-cell culture growth medium
containing 10% FCS (41). Before all experiments, the cells were
washed three times with serum-starved medium (3% FCS) and
further incubated for 30 min with the same medium before
initiation of experiments. All experiments were performed with
the serum-starved medium.
Study Design
The aim of this study was to establish a multicellular
proinflammatory TME culture in vitro (Figures 1A, B).
As “basal control,” CRC cells (HCT116) encapsulated in 3D-
alginate beads, were cultured alone.
To establish the “multicellular proinflammatory TME” culture,
stromal fibroblasts (MRC-5) were first seeded in monolayer (3,000
cells/cm2) andallowed to adhere to thebottomof thePetri dishes for
24 h in 10% FCS whole-cell culture growth medium. In the next
step, CRC cells were encapsulated in 3D-alginate beads as described
below. Finally, to establish the “multicellular proinflammatory
TME” cultures, these HCT116-alginate beads and T-lymphocytes
(Jurkat cells) (10,000/ml) were added to the Petri dishes containing
the monolayer fibroblasts and all co-cultured in serum-starved
medium (3% FCS).
To compare the “multicellular proinflammatory TME” and the
role of proinflammatory cytokines in the TME, additional
experiments were performed without T-lymphocytes but with
TNF-b (10ng/ml), and these were referred to as “TNF-b-
TME” cultures.A B
FIGURE 1 | Working model showing the experimental procedures of multicellular proinflammatory TME cultures as a scheme (A) and light microscopic photograph (B).September 2021 | Volume 11 | Article 650603
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alginate beads either alone (basal control) or in “multicellular
proinflammatory TME” culture or in “TNF-b-TME” culture
alone or in combination with Calebin A in a concentration-
dependent manner (1, 2, and 5 µM) for 10 days.
Alginate Bead Culture
3D-alginate bead cultures were prepared as previously described in
detail (40, 42). Briefly, CRC HCT116 cells (1 × 106/ml) were
resuspended in sterile liquid alginate (2% in 0.15 M NaCl, stirring
for 1–2 h), and this suspension was added dropwise to a sterile
CaCl2 solution (100 mM) where the drops polymerized to alginate
beads. After polymerizing of the beads in the CaCl2 solution for 15
min, the beads were washed three times with a NaCl solution (0.15
M) and twice with the whole-cell culture medium. Finally, the beads
were washed with serum-starved medium, incubated for 30 min
with serum-starved medium, and finally transferred to Petri dishes
that were either empty (for basal control) or contained MRC-5 in
monolayer for creating TME cultures.
Vitality Assay of CRC Cells From
Alginate Cultures
Viability and proliferation potential of CRC HCT116 cells in the
proinflammatory TME culture was evaluated by the MTT method
as described in detail (25). Briefly, alginate beads were dissolved for
20 min in a sterile 55 mM sodium citrate solution to release the
HCT116 cell from the alginate. After washing twice with balanced
Hank’s salt solution, HCT116 cells were resuspended in modified
whole-cell culture medium (without phenol red, without vitamin C,
3% FCS) and immediately distributed to a 96-well plate (100 µl cell
suspension/well) and 10 ml MTT solution (5 mg/ml) was added to
each well. After 3 h incubation, the reaction was blocked by adding
100 µl of MTT solubilization solution (10% Triton X-100/acidic
isopropanol) to each well. After overnight incubation at 37°C,
metabolically active tumor cells were determined by measuring
the optical density (OD) at 550 nm (OD550) using a revelation 96-
well multiscanner plate ELISA reader (Bio-Rad Laboratories Inc.
Munich, Germany).
Migration and Colony Formation Assay
CRC HCT116 cells were cultured in TME as described above,
and colonosphere formation and migration capacity were
investigated as previously described (23). Briefly, on day 10,
colonosphere formation in the beads was quantified by counting
20 microscopic fields with a phase-contrast microscope (Zeiss,
Germany), and images were digitally stored. The invasion was
quantified by staining adhered colonies at the bottom of the Petri
dish with toluidine blue, colonies manually counted under a light
microscope (Zeiss, Germany), and images captured and
digitally stored.
Immunofluorescence Labeling
For immunofluorescence investigations, the “multicellular
proinflammatory TME” culture described above was slightly
modified (Figure 4). Stromal fibroblasts were seeded in a
monolayer on the bottom of a Petri dish (3,000 cells/cm2), and
CRC cells HCT116 were seeded separately in a monolayer onFrontiers in Oncology | www.frontiersin.org 4glass plates (5,000/glass plate); the cells were let to adhere for 24 h
in whole-cell culture growth medium (10% FCS). To establish
the “multicellular proinflammatory TME” cultures, the HCT116-
containing glass plates were placed on a steel net bridge into the
Petri dishes containing the fibroblast culture, and T-lymphocytes
(10,000/ml) were added. To allow the development of
proinflammatory TME conditions, cultures were kept in a
serum-starved medium for 24 h before starting treatment
(Figure 4). To compare the “multicellular proinflammatory
TME” and the role and potential of proinflammatory cytokines
in the TME, additional experiments for immunofluorescence
were performed without T-lymphocytes but with TNF-b (10 ng/ml),
and these were referred to as “TNF-b-TME” cultures. For
“basal control,” CRC cells were cultured on glass plates
(5,000/glass plate) alone. For the experiments, they were either
cultured alone (basal control) or cultured in “multicellular
proinflammatory TME” or in “TNF-b-TME” alone or in
combination with Calebin A in a dose-dependent manner
(1, 2, and 5 µM) for 4 h.
For immunofluorescence investigation, HCT116 cells were
was fixated with methanol, washed in phosphate-buffered saline
(PBS), and incubated overnight (4°C) with primary NF-kB
antibodies [dilution 1:100 in PBS/bovine serum albumin (BSA
1%)], followed by secondary antibody incubation (rhodamine-
coupled, 1:100) for 2 h. Finally, to visualize nuclei, samples were
stained with DAPI for 15 min, embedded with Fluoromount
(Sigma-Aldrich, Germany), and images were captured with a
Leica DM2000 microscope (Wetzlar, Germany) and digitally
stored. Quantification of apoptotic nuclei and NF-kB positively
labeled cells was performed by counting 400–500 cells in 20
microscopic fields.
Immunoblotting
Western blot investigation of whole-cell lysates from HCT116
alginate beads was performed as described before (40). HCT116
cells were cultured in TME as described above and dissolved for
20 min in a sterile 55 mM sodium citrate solution to release the
HCT116 cell from the alginate. After subsequent washing with
Hank’s balanced salt solution, proteins were extracted on ice with
lysis buffer [50 mM Tris/HCl, pH 7.2/150 mMNaCl/(v/v) Triton
X-100/1 mM sodium orthovanadate/50 mM sodium
pyrophosphate/100 mM sodium fluoride/4 µg/ml pepstatin A/1
mM phenylmethylsulfonyl fluoride (PMSF)] for 30 min. After
centrifugation for 30 min at 10,000 g supernatant was stored at
−80°C. Total protein content was measured with the
bicinchoninic acid system (Uptima, France) using BSA as
standard. Proteins were reduced with 2-mercaptoethanol and
total protein concentrations adjusted (500 ng per lane total
protein). Finally, proteins were separated by sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE), blotted
onto a nitrocellulose membrane using a transblot apparatus (Bio-
Rad, Munich) and, after blocking (skimmed milk powder 1% in
PBS), primary antibodies (1:10,000) incubated overnight at 4°C.
After additional washing, membranes were incubated for 1 h
with secondary alkaline-phosphatase coupled antibodies
(1:10,000), and specific binding was detected using nitro blue
tetrazolium and 5-bromo-4-chloro-3-indoyl-phosphate (VWR,September 2021 | Volume 11 | Article 650603
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and densitometric quantification of bands was performed with
the Quantity One program (Bio-Rad, Munich).
Statistical Evaluation
All assays were performed three times as single assays using three
different replicates. AWilcoxon–Mann–Whitney test was used for
statistical analysis. The resultswere presented asmean+SDorSEM
and compared by one-, two-, or three-way ANOVA using SPSS
Statistics if the normality test was passed (Kolmogorov–Smirnov
test). A p-value of <0.05 was considered to detect statistically
significant differences in the study.RESULTS
The purpose of this study was to investigate the effect of Calebin
A on 3D-alginate HCT116 CRC cells with an in vitro coculture of
the multicellular TME (stromal components: MRC-5 fibroblast
cells and T-lymphocytes) model (Figures 1A, B) to provide an in
vivo approach of TME. This model helps to clarify the role of
multicellular TME-induced inflammation and how these actions
might be linked by specific signaling pathways during the
initiation and development of human CRC.
Calebin A Blocks CRC Cell Proliferation
Promoted by Multicellular
Proinflammatory TME
To examine the significance of inflammatory TME condition in
CRC progression, we first investigated the proliferation capacity
of HCT116 cells in 3D-alginate cultures alone (basal control) or
co-cultured with MRC-5 fibroblasts and T-lymphocytes
(multicellular proinflammatory TME cultures) and/or treated
with TNF-b and/or with Calebin A (Figures 1A, B), by the MTT
assay, as described in Materials and Methods. It has beenFrontiers in Oncology | www.frontiersin.org 5previously shown that TNF-b as a proinflammatory cytokine
promotes CRC cell malignancy (43). Therefore, to show that
TNF-b is one of the most important proinflammatory cytokines
produced by leukocytes, we also conducted a comparative
experiment with TNF-b alone in parallel assays to lymphocytes.
As shown in Figure 2, multicellular proinflammatory TME
with T-lymphocytes or with TNF-b alone was found to
significantly increase HCT116 cell proliferation, compared with
basal control. On the contrary, cotreatment of these cells with
Calebin A showed a marked dose-dependent decrease compared
to the excess proliferation of CRC cells induced in both cases,
and the maximum growth inhibition was observed in response to
5 µM Calebin A (Figure 2). This dose was selected for the
subsequent investigations. Taken together, these results suggest
that Calebin A indeed showed superior antitumor potency in a
3D-alginate stimulated multicellular proinflammatory TME.
Calebin A Downregulates CRC Cell Colony
Formation and Migration Promoted by
Multicellular Proinflammatory TME
To examine that Calebin A mediates its antitumor actions in
multicellular proinflammatory TME cultures through inhibition
of colony formation and migration, the CRC cells were treated as
described in detail in Materials and Methods, and the response
was evaluated by phase-contrast light microscopy.
Additionally, HCT116 cells were investigated in alginate
microenvironment cultures, without MRC-5 fibroblasts and T-
lymphocytes as a basal control. As demonstrated in Figure 3,
multicellular proinflammatory TME with T-lymphocytes or
with TNF-b by itself prompted and significantly increased the
number of colonosphere formations (Figures 3A, C) and
invasion (Figures 3B, D) in HCT116 cells compared to that in
basal control cultures, suggesting the pivotal role of multicellular
proinflammatory TME cultures-mediated malignant potential of
CRC cells. On the contrary, the concomitant treatment withFIGURE 2 | Effects of Calebin A on multicellular proinflammatory TME-induced HCT116 cell proliferation in 3D-alginate culture. Serum-starved cultures of HCT116
cells in 3D-alginate cultures alone (basal control = co) or co-cultured with fibroblasts and T-lymphocytes (proinflammatory multicellular TME) or co-cultured with
fibroblasts and TNF-b (10 ng/ml) (TNF-b-TME) were either left untreated or treated with various concentrations of Calebin A (CA) (1, 2, and 5 µM) for 10 days in
alginate cultures, and cell viability and proliferation were evaluated with the MTT assay, as described in Materials and Methods. All assays were performed with at
least three independent replicates. *p < 0.05 and **p < 0.01 indicate a significant difference compared to the control group.September 2021 | Volume 11 | Article 650603
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formations (Figures 3A, C) and invasion (Figures 3B, D) in
CRC cells in the TME co-cultures compared to that of control
cultures. Taken together, these results underline that
proinflammatory TME can stimulate malignancy of the tumor
cells, and Calebin A exhibits anticancer and anti-invasive
attributes in this multicellular proinflammatory TME.Calebin A Decreases Multicellular
Proinflammatory TME-Induced Activation
and Nuclear Translocation of p65-NF-kB
in CRC Cells
It is known that proinflammatory cytokines promote tumor cell
growth and invasion through activation of transcription factor NF-
kB (18); therefore, we explored the expression and nuclear
translocation of NF-kB associated with malignancy and survival of
CRC cells and performed immunofluorescence labeling for p65-NF-
kB as described inMaterials and Methods. In the untreated control
multicellular proinflammatory TME cultures, 98% of HCT116 cells
revealed strong positive labeling for p65-NF-kB in the nucleus. A
similar positive signal was observed in the TNF-b stimulated TME
cultures (97%), while HCT116 cells as basal control showed 84%
nuclear labeling (Figures 4A–C). Interestingly, treatment with
Calebin A lowered the nuclear staining and nuclear translocationFrontiers in Oncology | www.frontiersin.org 6of p65-NF-kB in CRC cells in a dose-dependent manner (1, 2, and 5
µM) inbothmulticellularproinflammatoryTMEcultures (85%,37%,
and 21%) and in TNF-b-TME (76%, 30%, and 22%), respectively,
suggesting the essential synergistic role of the paracrine interaction
between HCT116, MRC-5 cells, and T-lymphocytes/TNF-b in
maintaining tumor promotion. Taken together, these results
suggest further that Calebin A modulates the tumorigenic impact
promotedbyproinflammatory cytokineTNF-borT-lymphocytes, at
least in part by the suppression of the NF-kB signaling pathway.
Furthermore,we examined the extent of cell death by apoptosis using
DAPI staining and fluorescence microscopy to understand the
nuclear morphological changes that occurred during Calebin A
treatment (Figure 4C). In the untreated multicellular
proinflammatory- and TNF-b-TME cultures, HCT116 cells
displayed usual nuclear size and minimal morphological changes
resulting in 4% and 6% of the cells in apoptosis, similar to basal
control cultures (4%). In contrast, a significant gain in fragmented
nuclei and apoptotic morphological changes were observed in
HCT116 cells co-treated with Calebin A in a dose-dependent
manner with 14%, 35%, and 59% in multicellular proinflammatory
TME co-cultures and with 16%, 37%, and 48% in TNF-b-TME co-
cultures, respectively (Figure 4C). These results are in concordance
with data from the MTT assay and support the fact that Calebin A
significantly blocks protumorigenic effects of the proinflammatory
TME in CRC cells by inducing apoptosis (Figure 4C).A
B
DC
FIGURE 3 | Effects of Calebin A on multicellular proinflammatory TME-induced HCT116 cell colony formation and invasion in 3D-alginate culture. Serum-depleted
cultures of HCT116 cells in 3D-alginate (*) cultures alone (co) or co-cultured with fibroblasts (MRC-5) and T-lymphocytes (Jurkat) or cocultured with fibroblasts and
TNF-b (10 ng/ml) were either left untreated or treated with different concentrations of Calebin A (CA) as described in Materials and Methods. (A) Colonosphere
formation and (B) invasion were examined by light microscopy after 10 days. All experiments were performed at least three times. The number of colonospheres
(A, arrows) was quantified by counting 20 different microscopic fields (C), and the number of attached colonies as invasion parameter stained with toluidine blue was
quantified in each well (D). *p < 0.05 and **p < 0.01 indicate a significant difference compared with the control group. Magnification A: 24×, bars = 0.2 mm.September 2021 | Volume 11 | Article 650603
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Proinflammatory TME-Induced NF-kB
Activation and NF-kB-Regulated Gene
End-Products in CRC Cells
Given that activation of the transcription factor NF-kB signaling
cascade mediates the stimulation of the proinflammatory TME
in CRC, we sought to examine if Calebin A had the potential in
inhibiting TME-promoted NF-kB activation and NF-kB-
promoted gene products involved in proliferation (Ki-67),
invasion (MMP-9), metastasis (CXCR4, b1-integrin), and
apoptosis (cleavage of Caspase-3). The multicellular TME
cultures were treated or either left untreated as described in
Materials and Methods. Additionally, HCT116 cells alone in the
alginate microenvironment were used as basal control. To evaluate
whether Calebin A inhibits the TME-induced activation of NF-kB,
HCT116were examined for the phosphorylated formof the p65-NF-
kB subunits. The results demonstrated that significantly more
activation of p65 subunit in multicellular proinflammatory- and
TNF-b-TME compared to basal control HCT116 alginate cultures.
Calebin A significantly inhibited themulticellular proinflammatory-
or TNF-b-TME-induced phosphorylation of p65 subunits in a
concentration-dependent manner in HCT116 cells. Furthermore,
the expression of mentioned NF-kB-promoted gene products was
markedly upregulated in the multicellular proinflammatory TME
and TNF-b-TME cultures compared to basal control HCT116
alginate cultures (Figure 5). Calebin A treatment in these culturesFrontiers in Oncology | www.frontiersin.org 7downregulated the expression of mentioned NF-kB-promoted gene
products in a concentration-dependent manner (Figure 5).
Densitometric analysis of Western blot experiments confirmed
dose dependently the downregulation of NF-kB, Ki-67, MMP-9,
CXCR4, and b1-integrin, and upregulation of apoptosis (cleavage of
caspase-3) in HCT116 cells in TME cultures treated with Calebin A
(Figure 5). These results are in agreement with the previous reports
that suggest that proinflammatory agents areupregulated in theTME
(44–46) and are regulated by proinflammatory transcription factor
NF-kB (47). In addition, it is in concordance with the suppression of
p65-NF-kB observed through immunofluorescence analysis in the
current study, and with the existing literature that describes the
potential of Calebin A in proinflammatory monocellular-TME
culture (39). Taken together, these findings underline that the
multicellular proinflammatory TME promotes HCT116 tumor cell
progression, at least in part through NF-kB signaling pathways, and
this pathway could be specifically inhibited by Calebin A. Thus,
Calebin-A-mediated regulation of the NF-kB signaling pathway
might exert an antitumorigenic effect in CRC tumor.
Cancer Stem Cells Are Targeted in
Multicellular Proinflammatory TME
Co-Cultures by Calebin A
It has been previously reported that the TME plays an important
role in the induction of the cancer stem cells (CSCs) affected by
stroma, inflammatory cells, cytokines, and growth factorsA
B
C
FIGURE 4 | Effect of Calebin A on multicellular proinflammatory TME-induced activation and nuclear translocation of p65-NF-kB in CRC cells. (A) Schematic
representing the experiment model of the HCT116 cells in TME for immunofluorescence assay. (B) Serum-starved HCT116 cells in monolayer cultures alone (co) or
co-cultured with fibroblasts and T-lymphocytes or co-cultured with fibroblasts and TNF-b (10 ng/ml) were either left untreated, or treated with various concentrations
of Calebin A (CA) (1, 2, and 5 µM), as described in Materials and Methods. Magnification 600×; scale bar = 30 mm. All experiments were performed at least in
triplicate, and quantification of positively labeled p65-NF-kB-nuclei and apoptotic nuclei (white arrows) were performed by counting 400–500 cells from 20 different
microscopic fields (C). Values were compared with the control, and *p < 0.05 and **p < 0.01 were considered statistically significant.September 2021 | Volume 11 | Article 650603
Buhrmann et al. Calebin A Effects on CRC-TMEsecreted by the stromal fibroblasts (48, 49). Therefore, we
investigated the reaction of CSCs within the CRC cell
population, and multicellular proinflammatory TMEs of
HCT116 cells were either left untreated or treated as described
inMaterials and Methods. In addition, HCT116 cells alone in the
alginate microenvironment were used as basal control for theseFrontiers in Oncology | www.frontiersin.org 8experiments. We examined CSC markers (CD133, CD44, and
ALDH1) expression for tumor formation capacity and the
potential effect of Calebin A on these CSC markers. Control
alginate microenvironment cultures (without MRC-5 fibroblasts
or T-lymphocytes) of HCT116 cells showed basal expression of
CSC markers (Figure 6). Contrary to this, the immunoblottingFIGURE 5 | Effect of Calebin A on multicellular proinflammatory TME-induced activation of NF-kB and NF-kB-regulated gene end-products in CRC cells. Serum
starved cultures of HCT116 cells in 3D-alginate cultures alone (co) or co-cultured with fibroblasts and T-lymphocytes or co-cultured with fibroblasts and TNF-b (10
ng/ml) were either left untreated or treated with various doses of Calebin A (CA) (1, 2, and 5 µM), as described in Materials and Methods. Immunoblotting of whole-
cell lysates from HCT116 was performed for anti-p65-NF-kB, anti-phospho-p65-NF-kB, anti-b1-integrin, anti-MMP-9, anti-CXCR4, anti-Ki67, and anti-cleaved-
caspase-3. b-Actin served as an internal loading control in all experiments. For densitometric evaluation, results are compared to control, and *p < 0.05 and **p < 0.01
were considered statistically significant.September 2021 | Volume 11 | Article 650603
Buhrmann et al. Calebin A Effects on CRC-TMEinvestigation showed notable upregulated levels of CD133,
CD44, and ALDH1 in HCT116 cells from multicellular and
TNF-b-TME cultures (Figure 6). However, treatment with
Calebin A significantly downregulated CSC marker expression
in a concentration-dependent manner, suggesting the prominent
targeting effect of Calebin A on CSCs (Figure 6). Densitometric
analysis of Western blot experiments showed and confirmed the
above-mentioned results (Figure 6). Altogether, these results
suggest that the paracrine interaction between tumor, stromal
cells, and T-lymphocytes in 3D-alginate multicellular
proinflammatory TME cultures are essential in directing CSCs
phenotype. These findings further underline the essential role of
Calebin A in modulating multicellular proinflammatory-, similar
to TNF-b-TME-enhanced and stimulated CSCs. Moreover, these
results further suggest that the antitumorigenic effects of Calebin
A are, in part, mediated through the downregulation of the CSCs
pathway and also the through inhibition of NF-kB activation.Frontiers in Oncology | www.frontiersin.org 9DISCUSSION
The modulation of tumor and stromal cells in the TME is crucial
for tumor cell progression and malignancy. To better understand
the underlying paracellular interaction between different cells in
TME, we have created a new 3D-alginate multicellular
proinflammatory TME model (Figures 1A, B) composed of
tumor cells, stromal fibroblasts cells, and T-lymphocytes that
better mimics the in vivo heterogeneous proinflammatory TME.
In the present study, we have shown how Calebin A (a
component of Curcuma longa), at least partially, modulates the
inflammation-promoted survival and progression of CRC cells.
The results of this study indicated that Calebin A blocked the
proliferation, migration, and vitality of HCT116 cells in 3D-
alignate multicellular proinflammatory TME culture and
inhibited the activation of the transcription factor p65-NF-kB
and its nuclear translocation. Calebin A was found toFIGURE 6 | Effect of Calebin A on multicellular proinflammatory TME-induced activation of cancer stem cells. Serum-starved cultures of HCT116 cells in 3D-
alginate cultures alone (basal control = co) or co-cultured with fibroblasts and T-lymphocytes (proinflammatory multicellular TME cultures) or co-cultured with
fibroblasts and TNF-b (10 ng/ml) (TNF-b-TME) were either left untreated or treated with various concentrations of Calebin A (CA) (1, 2, and 5 µM), as described
in Materials and Methods. Immunoblotting of whole-cell lysates from HCT116 cells was performed for anti-CD133, anti-CD44, and anti-ALDH1 in HCT116 cells.
b-Actin served as an internal loading control in all experiments. Densitometric values were compared with the control, and *p < 0.05 and **p < 0.01 were
considered statistically significant.September 2021 | Volume 11 | Article 650603
Buhrmann et al. Calebin A Effects on CRC-TMEsignificantly suppressed NF-kB-promoted gene products
associated with cell survival, proliferation, and metastasis and
induced apoptosis in multicellular proinflammatory TME
cocultured with T-lymphocyte cultures, and TNF-b induced
TME. In addition, Calebin A targeted and inhibited CSCs of
the CRC population in the multicellular proinflammatory TME
cultures and TNF-b-TME. To our knowledge, we have shown for
the first time that the cytokine TNF-b-TME mediates
proinflammatory signals in alginate HCT116 3D-alginate,
similar to T-lymphocytes multicellular TME, which underlines
the important role of this cytokine in the proinflammatory
progression of CRC cells.
In vitro 3D-TME models have become an indispensable asset
in the evaluation of tumor cell dynamics before in vivo research.
These models are recognized as intermediatory between in vitro
cancer cell cultures and in vivo investigation (40, 50–55). The 3D-
TME models have gained increasing popularity in tumor cell
research, preclinical tumor research, and drug discovery because
these models recapitulate the essential properties of in vivo tumor
conditions (e.g., cell adhesion, crosstalk, microenvironment, and
necrosis) that cannot be reproduced in conventional 2D-tumor
cultures in monolayers. Due to the lack of a tumor-specific
architecture in 2D-tumor models, the cells represent a decreased
malignant phenotype compared to the tumor cells of in vivo
settings (54, 56, 57). For these reasons, the results of 2D-cultures
obtained in in vitro conditions often cannot be reproduced in
in vivo conditions.
Increasing experimental evidence over the past decades has
implicated chronic inflammation as a significant and important
trigger mechanism for the development of various cancers (58,
59). Previous studies have also reported that chronic inflammation
with a low tumor grade modulates the intricate cross-talk between
tumor cells and their immediate microenvironment, thereby
dramatically increasing the malignancy potential of tumors (20,
60). In fact, environmental stress factors are responsible for 95% of
cancers incidence because they mediate and trigger chronic
inflammation in patients (20). Interestingly, several studies
suggested that proinflammatory cytokines such as members of
the TNF family play a key role in cancer initiation and progression
(60, 61). Furthermore, in studies reported by our laboratory and
others as well, it has already been shown that the proinflammatory
cytokine TNF-b promotes tumor progression and thus activates
CRC cells malignancy (HCT116 cells and HCT116 5-FU resistant
cells) with the same efficacy as TNF-a (23, 62, 63). These data
highlight an essential role of TNF-b in the inflammatory
environment and in the stimulation of the ongoing TME
interactions. In addition, it has been reported that TNF-b
produced by tumor-associated lymphocytes in the TME induces
angiogenesis by signaling via the canonical NF-kB signaling
pathway (26). In addition, autocrine signaling of TNF-b was
shown to promote disease progression by maintaining NF-kB
phosphorylation in Hodgkin’s lymphoma (63).
In order to investigate and better establish the role of the
proinflammatory cytokine TNF-b in inflammation-induced
TME in CRC, we conducted comparative experiments between
TME with T-lymphocytes and TME with TNF-b. Moreover, it isFrontiers in Oncology | www.frontiersin.org 10known that the inflammation and associated with an
upregulation of proinflammatory mediators such as IL-1b, IL-
6, IL-8, and TNF-a, and prostaglandins by leukocytes play a
major role in tumor development in TME (64–67). In addition,
several studies from other laboratories including our own have
previously reported that Calebin A shows significant anti-
inflammatory effects in the migration, proliferation, and
invasion of tumor cells (23, 35, 37). Furthermore, in
accordance with our recently published findings, Calebin A has
been demonstrated to inhibit TNF-b-induced survival, invasion,
and antiapoptotic capacity in CRC cells in vitro (23, 39, 68).
However, in the current work, we have shown for the first time
the suppression of proliferation, survival, and migration of CRC
cells by Calebin A in a multicellular proinflammatory TME
HCT116 3D-alginate culture mimicking physiological TME.
We have revealed that Calebin A alone significantly induced
apoptosis in the multicellular proinflammatory TME of HCT116,
similar to TNF-b-TME, probably by suppressing the activation,
phosphorylation of NF-kB and its translocation in the nucleus in
HCT116 cells. Suppression of phosphorylation and activity of NF-
kB subunits could be a potential therapy and chemopreventive
intervention in colon carcinogenesis by Calebin A. To support this
assumption, in previous studies, Calebin A treatment was found to
sensitize human lung, cervical cancer, andCRC cells to paclitaxel or
cisplatin or 5-FU effectively inhibiting the NF-kB pathway (23, 37,
39).We also found thatCalebinA suppresses the expression of gene
products associatedwith cell proliferation (Ki-67), invasion (MMP-
9), metastasis (CXCR4, integrin b1), and apoptosis (Caspase-3) in
HCT116 multicellular proinflammatory TME and TNF-b-TME.
Since these tumorigenic proteins are promotedbyNF-kB, it is likely
that the suppression of NF-kB contributes to the downmodulation
of these proteins. These data suggest that Calebin A may be able to
act as an active multitargeting anticancer agent, and its action is
partially mediated by the suppression of NF-kB and NF-kB-
induced gene products in CRC-TME cells.
Our results in this study showed that T-lymphocytes activated
NF-kB and NF-kB-promoted proteins in HCT116 CRC cells in
multicellular TME cultures, similar to the proinflammatory
cytokine TNF-b-TME. Furthermore, it is known that NF-kB is
stimulated by different cytokines or growth factors in different
tumor cells (69, 70). In the past, TNF-b, a member of the TNF
family, has been reported to trigger inflammatory effects in CRC
cells with a potency similar to TNF-a (25, 62). We have also
previously reported that TNF-b promoted NF-kB activation, and
this was suppressed by other natural substances such as resveratrol
or curcumin (25, 40, 62). Recently, our group reported that TNF-b
stimulates the NF-kB signaling pathway and NF-kB-induced gene
products in CRC tumor cells, which was associated with survival,
proliferation, invasion, andepithelial-to-mesenchymal transitionof
tumor cells (25, 62), similar to the results of multicellular
proinflammatory TME in the current study. These results
underline that the cytokine TNF-b, like TNF-a, is one of the
most important cytokines in inflammatory multicellular TMEs
that are produced by T-lymphocytes (67).
In order to better understand the mechanism involved in the
survival and proliferation of tumor cells in the TME, it might beSeptember 2021 | Volume 11 | Article 650603
Buhrmann et al. Calebin A Effects on CRC-TMEimportant to identify other types of new targets for the
chemopreventive and chemotherapeutic agent Calebin A. In
the current study, we have also found for the first time that the
expression of cancer stem cells (CSC) in the HCT116 cell
population was significantly increased in multicellular pro-
inflammatory-, similar to TNF-b-TME cultures, compared to
HCT116 alginate basic control cultures. These results dictate that
multicellular pro-inflammatory TME is a fundamental factor that
induces and supports the formation of CSCs subpopulations.
Furthermore, it has been reported in the literature earlier that
CSCs are responsible for the onset, aggressiveness, progress, and
resistance of the cancer population (71, 72). Interestingly, CalebinA
was shown to inhibited the expression of various stem cell markers
(CD44, CD133, and ALDH1) in HCT116 multicellular
proinflammatory TME and TNF-b-TME cultures. Accumulating
evidence has reported that CSCs are one of the main reasons for
therapy resistance, therapy failure, and tumor recurrence (73–75),
which underlines the potentially important role of Calebin A in
preventing tumor cell proliferation, invasion, metastasis, and
induction of apoptosis in tumor cells. These results suggest that
when designing new approaches in cancer treatment, attention
shouldbepaid to the specific target the interactionsTMEandCSCs.
These data are consistent with results fromother studies suggesting
that other natural agents such as curcumin and resveratrol
significantly reduced the expression of CSC biomarkers in CRC
cells (24, 76).Overall, themodulation of interaction inmulticellular
proinflammatoryTME, similar to TNF-b-TME cultures byCalebin
A, could be a novel therapeutic approach to targeting inflammation
during CRC pathogenesis.
In conclusion, most malignant tumors, including colon
cancer, represent very dynamic structures that create new
tumor cell with morphological and genotypical changes within
the tumor mass. Such malignancies present a highly variable
sensitivity to therapeutics and incur resistance to the treatment.
In combinatorial approaches involving conventional therapies
with plant-derived molecules with proven cytotoxic,
multitargeted effects should be superior compared to cancer
monotherapy and may delay the development of drug
resistance in cancer (77). Therefore, further research warrants
the need for the identification of new molecules (including plant-Frontiers in Oncology | www.frontiersin.org 11derived compounds) with well-validated anticancer properties
for further progressing the novel and more efficacious therapies
within the clinical oncology. Such multicellular-TME-based
models and investigations are crucial for their heterogenicity
similar to those under in vivo conditions, and this is pivotal for
the discovery, screening, and testing of new, promising
anticancer drugs and strengthening preclinical and clinical
research. The critical role of the multicellular TME in
controlling tumor progression and metastasis is now widely
recognized. Hence, the targeted attack on the formation of a
specialized microenvironment, and thus the inhibition of the
survival and growth of tumor cells or CSCs by a multitargeted
drug such as Calebin A, is therefore of great clinical relevance in
the future of cancer medicine.DATA AVAILABILITY STATEMENT
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